The ROE as of September 2024 (TTM) for Sonoma Pharmaceuticals, Inc. (SNOA) is -77.69%

According to Sonoma Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -77.69%. This represents a change of 291.11% compared to the average of -19.86% of the last 4 quarters.

Sonoma Pharmaceuticals, Inc. (SNOA) Historical ROE (quarterly & annually)

How has SNOA ROE performed in the past?

The mean historical ROE of Sonoma Pharmaceuticals, Inc. over the last ten years is -65.27%. The current -77.69% ROE has changed 19.02% with respect to the historical average. Over the past ten years (40 quarters), SNOA's ROE was at its highest in in the December 2016 quarter at 70.98%. The ROE was at its lowest in in the December 2014 quarter at -75.55%.

Sonoma Pharmaceuticals, Inc. (SNOA) ROE by Quarter and Year

Discovering the peaks and valleys of Sonoma Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sonoma Pharmaceuticals, Inc. (SNOA) Average ROE

How has SNOA ROE performed in the past?

The current ROE of Sonoma Pharmaceuticals, Inc. (SNOA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Sonoma Pharmaceuticals, Inc. (SNOA) ROE vs. Peers

How is SNOA’s ROE compared to its peers?

Sonoma Pharmaceuticals, Inc.’s ROE is greater than China Pharma Holdings, Inc. (-60.19%), greater than Universe Pharmaceuticals INC (-14.22%), less than Acorda Therapeutics, Inc. (485.80%), greater than Akanda Corp. (-543.35%), greater than Petros Pharmaceuticals, Inc. (-134.64%), greater than Sunshine Biopharma, Inc. (-16.09%), greater than Guardion Health Sciences, Inc. (-71.26%), greater than Alpha Teknova, Inc. (-38.94%), less than Cannara Biotech Inc. (6.59%), less than MC Endeavors, Inc. (5.94%), less than Unrivaled Brands, Inc. (2.35%), less than GelStat Corporation (27.39%), less than Shionogi & Co., Ltd. (12.23%), greater than Alimera Sciences, Inc. (-33.70%), greater than China SXT Pharmaceuticals, Inc. (-195.84%), greater than Shuttle Pharmaceuticals Holdings, Inc. (-217.58%), less than Lifecore Biomedical, Inc. (26.37%), greater than Mallinckrodt plc (-117.04%), less than Journey Medical Corporation (5.44%),

Build a custom stock screener for Sonoma Pharmaceuticals, Inc. (SNOA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sonoma Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sonoma Pharmaceuticals, Inc. (SNOA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sonoma Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.